Ascites

Lore & Background

Ascites derives from the Greek word 'askos,' meaning a leather bag or wineskin, reflecting the bag-like swelling of the abdomen. The condition is detected through physical signs such as flank bulging, shifting dullness, and fluid wave, and is graded from mild (visible only on imaging) to severe (directly visible). In the developed world, cirrhosis is the most common cause, with over half of cirrhosis patients developing ascites within ten years of diagnosis.

Reader's Guide

Ascites is a significant clinical condition because it indicates advanced liver disease or other serious underlying disorders. In cirrhosis, ascites arises from portal hypertension and vascular dysfunction, and its development carries a poor prognosis: half of those who develop ascites die within three years. Diagnosis relies on physical examination, imaging, and analysis of ascitic fluid, with the serum-ascites albumin gradient helping distinguish transudative from exudative causes. Treatment focuses on salt restriction, diuretics like spironolactone, and therapeutic paracentesis for severe cases. Refractory ascites, which does not respond to diuretics, may require a transjugular intrahepatic portosystemic shunt or liver transplant. Complications such as spontaneous bacterial peritonitis further increase morbidity. Understanding ascites is crucial for managing chronic liver disease and improving patient outcomes.

Did You Know?

• Ascites is defined as more than 25 milliliters of fluid in the peritoneal cavity.
• In the developed world, the most common cause of ascites is liver cirrhosis.
• Of those with cirrhosis who develop ascites, half will die within three years.

The Clinical Picture: From Subtle Swelling to Massive Distension

Ascites ranges from a barely perceptible accumulation of fluid to a dramatic distension of the abdomen capable of holding as much as thirty-five litres. In its mildest form, the condition is nearly invisible to the naked eye and only revealed by imaging. As volume grows, patients typically report a progressive sense of heaviness and pressure in the belly, along with breathlessness caused by the fluid pressing upward against the diaphragm.

At the bedside, clinicians rely on a handful of classic physical manoeuvres. In a reclining patient, fluid collects along the flanks, producing a visible bulge. Percussion notes shift when the person is rolled onto their side, a finding known as shifting dullness. In massive cases, tapping one side of the abdomen generates a palpable wave that travels across to the opposite flank.

Beyond the abdomen, the underlying aetiology stamps its own signature on the patient. Portal hypertension may bring leg oedema, easy bruising, gynecomastia, vomiting of blood, or the confusion of hepatic encephalopathy. Malignant ascites often accompanies chronic fatigue and weight loss, while cardiac ascites adds wheezing and exercise intolerance. A feared complication, spontaneous bacterial peritonitis, can strike at any stage.

Etiology and the SAAG Framework

Understanding why fluid accumulates in the peritoneal cavity hinges on a single laboratory measurement: the serum-ascites albumin gradient, or SAAG. A gradient above 1.1 g/dL points to portal hypertension as the driving force, while a value below that threshold signals a non-portal mechanism such as inflammation or malignancy.

Among portal-hypertensive causes, liver cirrhosis dominates, accounting for roughly 81 percent of cases. Within that group, alcoholic aetiology represents about 65 percent, viral hepatitis around 10 percent, and a cryptogenic or unexplained cause makes up the remaining 6 percent. Heart failure contributes approximately 3 percent. Rarer portal-hypertensive culprits include Budd-Chiari syndrome, veno-occlusive disease, constrictive pericarditis, and the childhood protein-energy malnutrition known as kwashiorkor.

On the low-gradient side, metastatic or primary peritoneal cancer accounts for about 10 percent of ascites. Tuberculosis and spontaneous bacterial peritonitis each represent roughly 2 percent, pancreatitis about 1 percent, and the remainder is spread across serositis, nephrotic syndrome, and hereditary angioedema. Mechanistically, transudates arise from elevated portal pressures—often around 20 mmHg—whereas exudates are actively secreted by inflamed or malignant tissue, carrying higher protein, lower pH, and more white cells.

Diagnostic Workup and Imaging

Once ascites is suspected, the diagnostic pathway begins with routine blood work—complete blood count, basic metabolic profile, liver enzymes, and coagulation studies. Most specialists advocate a diagnostic paracentesis whenever the fluid is newly detected or the patient is being admitted to hospital. The aspirated sample is examined for gross appearance, protein, albumin, and cell counts. Depending on context, microbiological culture, Gram stain, or cytopathology may follow.

Imaging plays a complementary role. An ultrasound performed before any drainage attempt can reveal organ size and shape, estimate free-fluid volume, and, with Doppler studies, trace flow within the portal vein. It can also unmask Budd-Chiari syndrome or portal vein thrombosis. For difficult-to-drain collections, the sonographer may guide the needle in real time. When finer anatomical detail is needed, an abdominal CT scan offers superior resolution of organ structure compared with a sonogram.

Clinicians further stratify ascites into uncomplicated and refractory categories. Uncomplicated ascites—graded from ultrasound-only detection to a visible fluid wave—responds to salt restriction and diuretics. Refractory ascites, which recurs despite those measures, splits into diuretic-intractable and diuretic-resistant subtypes.

Treatment Pathways and Prognosis

Managing ascites is a layered effort that typically starts with dietary salt restriction and pharmacological diuresis, supplemented by periodic drainage of the accumulated fluid. For patients whose condition does not yield to these measures, a transjugular intrahepatic portosystemic shunt (TIPS) may be placed to relieve portal pressures, though the procedure carries its own complications. In the most severe cases, treating the root cause through a liver transplant becomes the definitive option.

The prognosis, however, remains sobering. Among patients diagnosed with cirrhosis, more than half will develop ascites within ten years. Of that subset, roughly half will die within three years of the fluid first appearing, underscoring how ascites marks a critical inflection point in the natural history of liver disease.

Refractory ascites, the form that persists or returns despite adequate diuretic therapy and salt restriction, is the most challenging variant. It divides into two subtypes: diuretic-intractable ascites, where the drugs cannot be escalated because of side effects such as rising creatinine or potassium depletion, and diuretic-resistant ascites, where the fluid simply does not respond to the medication. This distinction shapes the urgency with which clinicians consider shunt placement or transplantation.

Gallery